Hydrafacial LLC v. Medicreations LLC

CourtDistrict Court, D. Nevada
DecidedFebruary 28, 2025
Docket2:24-cv-00855
StatusUnknown

This text of Hydrafacial LLC v. Medicreations LLC (Hydrafacial LLC v. Medicreations LLC) is published on Counsel Stack Legal Research, covering District Court, D. Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hydrafacial LLC v. Medicreations LLC, (D. Nev. 2025).

Opinion

1 UNITED STATES DISTRICT COURT

2 DISTRICT OF NEVADA

3 HYDRAFACIAL LLC, 4 Plaintiff, Case No.: 2:24-cv-00855-GMN-MDC 5 vs. ORDER GRANTING IN PART 6 MEDICREATIONS LLC, DEFENDANT’S 7 PARTIAL MOTION TO DISMISS Defendant. 8 9 Pending before the Court is a Motion to Dismiss, (ECF No. 22), filed by Defendant 10 Medicreations. Plaintiff Hydrafacial filed a Response, (ECF No. 23), to which Defendant filed 11 a Reply, (ECF No. 24). For the reasons discussed below, the Court GRANTS in part the 12 Partial Motion to Dismiss. 13 I. BACKGROUND 14 This case arises out of Defendant’s alleged infringement on Plaintiff’s patents. (See 15 generally First Am. Compl. (“FAC”), ECF No. 20). Plaintiff designs, manufactures, and sells 16 skin resurfacing and rejuvenation systems, including microdermabrasion and 17 hydradermabrasion systems. (Id. ¶¶ 8–9). Plaintiff has received several patents for its products, 18 including the 12 at issue in this case, (the “Asserted Patents”). (Id. ¶¶ 10–23). The patents are 19 divided into the “Ignon Patents,” which include the ʾ052, ʾ089, ʾ641, ʾ642, ʾ477, and ʾ287 20 Patents, and the “Shadduck Patents,” which include the ʾ591, ʾ120, ʾ886, ʾ716, ʾ513, and 21 ʾ464 Patents. (Id. ¶¶ 22–23). The Shadduck Patents expired in August 2020, but Plaintiff 22 alleges that Defendant’s infringement occurred while those patents were still in effect. (Id. ¶ 23 22). 24 Defendant sources, advertises, and sells aesthetic medical devices, including devices that 25 allegedly infringe on Plaintiff’s patents. (Id. ¶¶ 24–37). Plaintiff alleges that Defendant had 1 actual knowledge of the Asserted Patents when it began making and selling the infringing 2 products or else acted with willful blindness to its infringement. (Id. ¶¶ 38–43). On October 21, 3 2020, Plaintiff sent a letter to Defendant informing it of the ʾ052, ʾ089, ʾ641, and ʾ642 4 Patents, (collectively, “the Demand Letter Patents”), and Defendant’s alleged infringement of 5 them. (Id. ¶ 44). Plaintiff brings 12 claims, Counts I-XII, for infringement of the 12 Asserted 6 Patents. (Id. ¶¶ 53–146). Defendant moves to dismiss Counts II-VII in their entirety and 7 Counts I and VIII-XII in part, pursuant to Rule 12(b)(6). (See generally Mot. Dismiss, ECF No. 8 22). 9 II. LEGAL STANDARD 10 Dismissal is appropriate under Rule 12(b)(6) where a pleader fails to state a claim upon 11 which relief can be granted. Fed. R. Civ. P. 12(b)(6). A pleading must give fair notice of a 12 legally cognizable claim and the grounds on which it rests, and although a court must take all 13 factual allegations as true, legal conclusions couched as factual allegations are insufficient. Bell 14 Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007). Accordingly, Rule 12(b)(6) requires “more 15 than labels and conclusions, and a formulaic recitation of the elements of a cause of action will

16 not do.” Id. “To survive a motion to dismiss, a complaint must contain sufficient factual 17 matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. 18 Iqbal, 556 U.S. 662, 678 (2009) (quoting Twombly, 550 U.S. at 570). “A claim has facial 19 plausibility when the plaintiff pleads factual content that allows the court to draw the 20 reasonable inference that the defendant is liable for the misconduct alleged.” Id. This standard 21 “asks for more than a sheer possibility that a defendant has acted unlawfully.” Id. 22 If the court grants a motion to dismiss for failure to state a claim, the court should grant 23 leave to amend “unless it determines that the pleading could not possibly be cured by the 24 allegation of other facts.” Lopez v. Smith, 203 F.3d 1122, 1130 (9th Cir. 2000) (quoting Doe v. 25 United States, 58 F.3d 494, 497 (9th Cir. 1995)). Pursuant to Rule 15(a), the court should 1 “freely” give leave to amend “when justice so requires,” and in the absence of a reason such as 2 “undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure 3 deficiencies by amendments previously allowed, undue prejudice to the opposing party by 4 virtue of allowance of the amendment, futility of the amendment, etc.” Foman v. Davis, 371 5 U.S. 178, 182 (1962). 6 III. DISCUSSION 7 Defendant argues that Plaintiff had not pleaded compliance with the marking statute, 8 actual notice of infringement, or willful and indirect infringement. (See generally Mot. Dismiss, 9 ECF No. 22). The Court begins with Defendant’s marking statute argument. 10 A. Compliance with the Marking Statute, 35 U.S.C. § 287(a) 11 Defendant first moves to dismiss seven of Plaintiff’s infringement claims for failure to 12 allege proper marking. (Id. 10:16–20). It argues that the FAC does not allege any form of 13 compliance with section 287(a) for the ʾ120 Patent, ʾ886 Patent, ʾ464 Patent, ʾ641 Patent, 14 ʾ642 Patent, ’477 Patent, or the ʾ287 Patent. (Id.). Section 287(a) limits a patentee’s ability to 15 recover damages for infringement, stating, in relevant part:

16 Patentees, and persons making, offering for sale, or selling within the United States any patented article for or under them, or importing any patented article 17 into the United States, may give notice to the public that the same is patented ... by fixing thereon the word “patent” . . . . In the event of failure so to mark, no 18 damages shall be recovered by the patentee in any action for infringement, except 19 on proof that the infringer was notified of the infringement and continued to infringe thereafter, in which event damages may be recovered only for 20 infringement occurring after such notice. Filing of an action for infringement shall constitute such notice. 21 22 35 U.S.C. § 287(a). “The patentee bears the burden of pleading and proving he 23 complied with § 287(a)’s marking requirement.” Arctic Cat Inc. v. Bombardier Recreational 24 Prods. Inc., 876 F.3d 1350, 1366 (Fed. Cir. 2017) (hereinafter “Arctic Cat I”). However, “[t]he 25 notice provisions of § 287(a) do not apply to patents directed to processes or methods.” Arctic 1 Cat Inc. v. Bombardier Recreational Prods. Inc., 950 F.3d 860, 865 (Fed. Cir. 2020) 2 (hereinafter “Arctic Cat II”) (citing Wine Ry. Appliance Co. v. Enter. Ry. Equip. Co., 297 U.S. 3 387, 395 (1936)). 4 Plaintiff responds that because the ʾ120, ʾ886, and ʾ464 Patents consist of only method 5 claims, it need not allege that the products are marked with a patent to recover damages. (Resp. 6 8:13–16); (see FAC ¶¶ 71, 76, 93) (alleging that these patents are for methods). The Court 7 agrees with Plaintiff. “The law is clear that the notice provisions of § 287 do not apply where 8 the patent is directed to a process or method.” Crown Packaging Tech., Inc. v. Rexam Beverage 9 Can Co., 559 F.3d 1308, 1316 (Fed. Cir. 2009). The marking statute does not apply to method 10 claims because ordinarily, “there is nothing to mark.” American Medical Systems, Inc. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Warsaw Orthopedic, Inc. v. Nuvasive, Inc.
824 F.3d 1344 (Federal Circuit, 2016)
The Science
5 U.S. 178 (Supreme Court, 1866)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)
Safari Club International v. Salazar
709 F.3d 1 (D.C. Circuit, 2013)
Eon Corp. IP Holdings LLC v. FLO TV Inc.
802 F. Supp. 2d 527 (D. Delaware, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Hydrafacial LLC v. Medicreations LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hydrafacial-llc-v-medicreations-llc-nvd-2025.